Skip to main content

Find Clinical Trials

Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)

NCT00771472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Not specified

View Trial Details

Completed

Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)

NCT00871663

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Not specified

View Trial Details

Completed

Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase

NCT00383474

Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia, +49 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00003210

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +51 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

NCT01065025

Conditions: Advanced and Incurable Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Universitätsklinikum Essen Essen, Germany

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg (KTB) Freiburg im Breisgau, Germany

View Trial Details

Completed

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

NCT00958256

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas

NCT01555242

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: BC Cancer Agency-Vancouver Centre Vancouver, British Columbia, Canada

View Trial Details

Completed

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

NCT00049400

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +41 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States

View all 23 locations

View Trial Details

Completed

Bendamustine and Bortezomib Combination Therapy in Indolent Non-Hodgkin's Lymphoma(NHL)

NCT00426855

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

NCT00919139

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +25 more
Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States

Peninsula Medical Center Burlingame, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View all 207 locations

View Trial Details